Sarah de Ferranti, MD, MPH Sarah de Ferranti is an Assistant in Pediatric Cardiology with Masters in Public Health. She directs the Preventative Cardiology Clinic at Children's Hospital Boston and has extensive experience working with hyperlipidemic and hypertensive children and their families. She is interested in the prevention of atherosclerosis clinically, and as a clinical researcher. 

Publications include works on pediatric metabolic syndrome, including "Prevalence of the Metabolic Syndrome in American Adolescents: Findings from the Third National Health and Nutrition Examination Survey (Circulation. 2004 Oct 19;110(16):2494-7), in which Dr. de Ferranti and her mentors proposed a definition of pediatric metabolic syndrome and described its prevalence. This was presented in abstract at the 2003 American Heart Association Scientific Sessions in Orlando Florida, and was followed by "Inflammation and Changes in Metabolic Syndrome Abnormalities in US Adolescents: Findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys (Clin Chem. 2006 Jul;52(7):1325-30), an analysis that explored inflammation in children with pediatric metabolic syndrome.

She was awarded the Sandra A. Daugherty Foundation Cardiovascular Prevention and Epidemiology Grant for a project entitled "Inflammation in Children at Risk for Atherosclerosis" and examined inflammatory markers in children with family history of early atherosclerosis and hyperlipidemia. Other research has included evaluating a non-fasting LDL cholesterol assay in healthy ethnically diverse children, as published in "Nonfasting Low-Density Lipoprotein Testing: Utility for Cholesterol Screening in Pediatric Primary Care," (Clinical Pediatrics 2007;46(5):441-5). Current research includes a randomized nutritional interventional study on overweight adolescents with cardiovascular risk factors. This is supported by an NIH career development award from NHLBI (5K23HL85308-2). In addition to the NIH K23 Career Development, Dr. de Ferranti is the recipient of the Eleanor and Miles Shore fellowship, a Children's Hospital Career Development Award; Dr. de Ferranti was also supported by the NIH Training grant T32 HL07572.